Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neoplasms × Dronabinol × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Pain 1 Neoplasms 1 Nausea 1 Brain Neoplasms 1

Interventions

pembrolizumab 67 Paclitaxel 57 Gemcitabine 51 Carboplatin 50 Cisplatin 40 Docetaxel 36 Bevacizumab 34 Nivolumab 30 Irinotecan 25 Cyclophosphamide 25 Pemetrexed 24 Fluorouracil 23 Capecitabine 22 Erlotinib Hydrochloride 20 Cetuximab 20 venetoclax 19 trametinib 17 Leucovorin 16 Topotecan 15 Afatinib 15 fludarabine 14 Radiotherapy 14 130-nm albumin-bound paclitaxel 14 regorafenib 13 budigalimab 13 Sorafenib 13 Oxaliplatin 13 atezolizumab 12 Midazolam 12 Doxorubicin 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06601218 2025-06-24

Impact of Daily Oral Cannabis Doses in Patients With Cancer

University of Kentucky

Phase 1 Recruiting

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡